| David L Kroninger, OD | |
|
910 Martin Luther King Jr Blvd, Chapel Hill, NC 27514-2655 | |
| (919) 942-8531 | |
| (919) 942-0719 |
| Full Name | David L Kroninger |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 910 Martin Luther King Jr Blvd, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841285863 | NPI | - | NPPES |
| 89-09498 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1107 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David L Kroninger, OD 910 Martin Luther King Jr Blvd, Chapel Hill, NC 27514-2655 Ph: (919) 942-8531 | David L Kroninger, OD 910 Martin Luther King Jr Blvd, Chapel Hill, NC 27514-2655 Ph: (919) 942-8531 |
News Archive
Obese adolescents not getting enough sleep? A study in today's The Journal of Pediatrics, shows they could be increasing their risk for developing diabetes, heart disease and stroke.
Clioquinol, an antibiotic that was banned for internal use in the United States in 1971 but is still used in topical applications, appears to block the genetic action of Huntington's disease in mice and in cell culture, according to a study reported by San Francisco VA Medical Center (SFVAMC) researchers.
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
In a new study, one Michigan State University professor will explore why in old age, blacks are much more likely to have dementia than whites.
Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. The findings by the Society for Endocrinology UK Acromegaly Register, published in the November issue of Clinical Endocrinology, show that drugs to control acromegaly often fail to bring the disease completely under control in routine clinical practice.
› Verified 9 days ago
Dr. Joshua Scott Sikes, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 235 S Elliott Rd, Chapel Hill, NC 27514 Phone: 919-968-4774 Fax: 919-492-5291 | |
Dr. Phillip C. Boykin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1201 Raleigh Rd Ste E, Chapel Hill, NC 27517 Phone: 919-942-2320 Fax: 919-942-7268 | |
Adler Eye Associates, O.d., P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 861 Willow Dr, Chapel Hill, NC 27514 Phone: 919-992-9711 | |
Laurel Beth Gropper, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 235 S Elliott Rd, Chapel Hill, NC 27514 Phone: 919-968-4774 Fax: 919-942-5291 | |
John Bryan Marshall, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11312 Us 15-501 North, Ste. 304, Chapel Hill, NC 27517 Phone: 919-933-6767 Fax: 919-933-6732 | |
Dr. Shirin Esmail, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 140 W Franklin St, Chapel Hill, NC 27516 Phone: 919-968-3937 Fax: 919-932-3290 | |
Dr. Michael Mendsen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2226 Nelson Hwy # 200, Chapel Hill, NC 27517 Phone: 607-972-4655 |